Read the full article.
Chen SK, Barbhaiya M, Fischer MA, et al. Lipid testing and statin prescription among medicaid recipients with systemic lupus erythematosus, diabetes mellitus and the general Medicaid population. 2019 Jan:71(1).
Arthritis Care & Research |
Read the full article.
Chen SK, Barbhaiya M, Fischer MA, et al. Lipid testing and statin prescription among medicaid recipients with systemic lupus erythematosus, diabetes mellitus and the general Medicaid population. 2019 Jan:71(1).
Information on safety, labeling changes, and pharmaceutical research
PHILADELPHIA—At ACR Convergence 2022, the much-anticipated ACR Review Course featured talks from eight experts. Topics reflected the heterogeneity of our field and included Sjögren’s disease, spondyloarthritis (SpA), osteoarthritis (OA), paraneoplastic rheumatic syndromes, metabolic bone disease, statin myopathy, Raynaud’s phenomenon and autoinflammatory syndrome. Here, I share highlights from this comprehensive, six-hour session. Sjögren’s Disease Sara S….
WASHINGTON, D.C.—Experts at the 2016 ACR/ARHP Annual Meeting session, Systemic Lupus Erythematosus—Clinical Aspects and Treatment IV: Biomarkers, reported on a number of recent studies showing advancement in our understanding of the disease mechanisms underlying systemic lupus erythematosus (SLE) that place these patients at risk for cardiovascular disease (CVD) and other comorbidities. Mechanisms of CVD Risk…
A recent epidemiologic study of patients with systemic lupus erythematosus (SLE) investigated racial and ethnic differences in the risk for cardiovascular disease (CVD). Among SLE patients enrolled in Medicaid, the risk for myocardial infarction (MI) was lower in Hispanics and Asians compared with whites, and the risk of stroke was higher in blacks and Hispanics…